New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
08:04 EDTSTJSt. Jude Medical launches U.S. study of new Prodigy neurostimulator
St. Jude Medical has initiated a clinical study of the Prodigy neurostimulator. The SUNBURST study will evaluate whether burst stimulation can be more effective in managing chronic pain than traditional tonic stimulation. The SUNBURST study is a randomized, prospective, multicenter, clinical study designed to demonstrate the safety and efficacy of the Prodigy neurostimulation system using tonic and burst stimulation therapy to manage patients with chronic intractable pain. A maximum of 442 patients will be enrolled at up to 50 sites in the U.S. The SUNBURST study is being conducted under an Investigational Device Exemption from the U.S. Food and Drug Administration. The Prodigy neurostimulator is not approved for use in the U.S.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
08:00 EDTSTJSt. Jude Medical price target lowered to $47 from $51 at Canaccord
Subscribe for More Information
April 16, 2014
15:39 EDTSTJBoston Scientific CRT-D approval neutral for St. Jude, says Wells Fargo
Subscribe for More Information
10:00 EDTSTJSt. Jude Medical falls 4.3%
Subscribe for More Information
08:33 EDTSTJSt. Jude Medical sees total Q2 CRM sales $705M-$735M
Subscribe for More Information
07:34 EDTSTJSt. Jude Medical sees FY14 consolidated adjusted EPS $3.95-$4.00
Subscribe for More Information
07:33 EDTSTJSt. Jude Medical sees Q2 consolidated adjusted EPS 99c-$1.01, consensus $1.00
Sees Q2 revenue $1.38B-$1.46B, consensus $1.44B.
07:31 EDTSTJSt. Jude Medical reports Q1 adjusted EPS 96c, consensus 95c
Subscribe for More Information
April 15, 2014
15:19 EDTSTJNotable companies reporting before tomorrow's open
Subscribe for More Information
09:23 EDTSTJBarclays medical supplies/devices analysts hold analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use